Goodwill of BIO-TECHNE Corp from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
BIO-TECHNE Corp quarterly Goodwill in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • BIO-TECHNE Corp Goodwill for the quarter ending 30 Sep 2025 was $978,912,000, a 0.37% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $978,912,000 -$3,673,000 -0.37% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $980,935,000 +$8,272,000 +0.85% 30 Jun 2025 10-Q 05 Nov 2025 2026 Q1
Q1 2025 $968,612,000 -$2,354,000 -0.24% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $964,607,000 -$15,475,000 -1.6% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $982,585,000 +$13,209,000 +1.4% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $972,663,000 +$99,926,000 +11% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $970,966,000 +$100,424,000 +12% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $980,082,000 +$110,493,000 +13% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $969,376,000 +$103,958,000 +12% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $872,737,000 +$50,636,000 +6.2% 30 Jun 2023 10-K 22 Aug 2025 2025 FY
Q1 2023 $870,542,000 +$42,924,000 +5.2% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $869,589,000 +$37,533,000 +4.5% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $865,418,000 +$22,351,000 +2.7% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $822,101,000 -$20,966,000 -2.5% 30 Jun 2022 10-K 22 Aug 2024 2024 FY
Q1 2022 $827,618,000 +$81,158,000 +11% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $832,056,000 +$103,746,000 +14% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $843,067,000 +$111,431,000 +15% 30 Sep 2021 10-Q 07 Feb 2022 2022 Q2
Q2 2021 $843,067,000 +$114,757,000 +16% 30 Jun 2021 10-K 23 Aug 2023 2023 FY
Q1 2021 $746,460,000 +$20,629,000 +2.8% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $728,310,000 -$5,931,000 -0.81% 31 Dec 2020 10-Q 07 May 2021 2021 Q3
Q3 2020 $731,636,000 +$1,224,000 +0.17% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $728,310,000 -$4,357,000 -0.6% 30 Jun 2020 10-K 24 Aug 2022 2022 FY
Q1 2020 $725,831,000 +$6,223,000 +0.86% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $734,241,000 +$27,886,000 +3.9% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $730,412,000 +$25,622,000 +3.6% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $732,667,000 +$134,777,000 +23% 30 Jun 2019 10-K 25 Aug 2021 2021 FY
Q1 2019 $719,608,000 +$108,941,000 +18% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $706,355,000 +$117,254,000 +20% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $704,790,000 +$117,010,000 +20% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $597,890,000 +$18,864,000 +3.3% 30 Jun 2018 10-K 26 Aug 2020 2020 FY
Q1 2018 $610,667,000 +$40,929,000 +7.2% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $589,101,000 +$31,370,000 +5.6% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $587,780,000 +$21,991,000 +3.9% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $579,026,000 +$148,144,000 +34% 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
Q1 2017 $569,738,000 +$135,004,000 +31% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $557,731,000 +$133,836,000 +32% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $565,789,000 +$138,472,000 +32% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $430,882,000 +$40,244,000 +10% 30 Jun 2016 10-K 27 Aug 2018 2018 FY
Q1 2016 $434,734,000 +$48,903,000 +13% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $423,895,000 +$22,244,000 +5.5% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $427,317,000 +$122,083,000 +40% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $390,638,000 +$239,165,000 +158% 30 Jun 2015 10-K 07 Sep 2017 2017 FY
Q1 2015 $385,831,000 +$241,177,000 +167% 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $401,651,000 +$257,290,000 +178% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $305,234,000 +$161,434,000 +112% 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $151,473,000 +$67,137,000 +80% 30 Jun 2014 10-K 29 Aug 2016 2016 FY
Q1 2014 $144,654,000 +$60,343,000 +72% 31 Mar 2014 10-Q 12 May 2014 2014 Q3
Q4 2013 $144,361,000 +$57,195,000 +66% 31 Dec 2013 10-Q 04 Feb 2014 2014 Q2
Q3 2013 $143,800,000 +$56,864,000 +65% 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q2 2013 $84,336,000 -$1,346,000 -1.6% 30 Jun 2013 10-K 31 Aug 2015 2015 FY
Q1 2013 $84,311,000 -$2,213,000 -2.6% 31 Mar 2013 10-Q 10 May 2013 2013 Q3
Q4 2012 $87,166,000 +$1,926,000 +2.3% 31 Dec 2012 10-Q 11 Feb 2013 2013 Q2
Q3 2012 $86,936,000 +$1,576,000 +1.8% 30 Sep 2012 10-Q 09 Nov 2012 2013 Q1
Q2 2012 $85,682,000 -$951,000 -1.1% 30 Jun 2012 10-K 29 Aug 2014 2014 FY
Q1 2012 $86,524,000 +$61,456,000 +245% 31 Mar 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 $85,240,000 +$60,172,000 +240% 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 $85,360,000 +$60,292,000 +241% 30 Sep 2011 10-Q 09 Nov 2011 2012 Q1
Q2 2011 $86,633,000 +$61,565,000 +246% 30 Jun 2011 10-K 29 Aug 2013 2013 FY
Q1 2011 $25,068,000 31 Mar 2011 10-Q 10 May 2011 2011 Q3
Q4 2010 $25,068,000 31 Dec 2010 10-Q 09 Feb 2011 2011 Q2
Q3 2010 $25,068,000 30 Sep 2010 10-Q 09 Nov 2010 2011 Q1
Q2 2010 $25,068,000 30 Jun 2010 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.